[1]丁思意,蒋媛媛,刘琴,等.过程能力指数在临床生化实验室中的运用[J].现代检验医学杂志,2015,30(05):169-172.[doi:10.3969/j.issn.1671-7414.2015.05.055]
　DING Si-yi,JIANG Yuan-yuan,LIU Qin,et al.Application of Process Capability Indices in the Clinical Biochemistry Laboratories[J].Journal of Modern Laboratory Medicine,2015,30(05):169-172.[doi:10.3969/j.issn.1671-7414.2015.05.055]
点击复制

过程能力指数在临床生化实验室中的运用()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第30卷
期数:
2015年05期
页码:
169-172
栏目:
质量控制·实验室管理
出版日期:
2015-12-10

文章信息/Info

Title:
Application of Process Capability Indices in the Clinical Biochemistry Laboratories
作者:
丁思意; 蒋媛媛; 刘琴; 蒋洪敏
中南大学湘雅二医院检验科，长沙410011
Author(s):
DING Si-yi; JIANG Yuan-yuan; LIU Qin; JIANG Hong-min
Department of Laboratory Medicine， the Second Xiangya Hospital of Central South University，Changsha 410011，China
关键词:
过程能力指数; 质量控制; Minitab软件
分类号:
R446
DOI:
10.3969/j.issn.1671-7414.2015.05.055
文献标志码:
A
摘要:
目的通过调查临床生化实验室11个检测项目的过程能力指数，将已在工业生产、公共服务等多个领域广泛应用的过程能力指数(Cp及Cpk)引入临床实验室。方法运用过程能力指数公式，结合Minitab软件计算11个生化检查项目两个质控浓度从2014年8月～2015年2月连续7个月的Cp及Cpk。结果低浓度质控血清中77个Cp中有16个Cp≤1.33，61个Cp>1.33；高浓度质控血清中77个Cp有9个Cp ≤1.33，68个Cp>1.33。结论过程能力分析是一种以数据和事实为决策依据的管理方法，是一种更为客观、全面、科学的管理方法。
Abstract:
ObjectiveTo introduce process capability indices (Cp and Cpk)，which have widely used in the industrial production，public services，and other fields，into the clinical laboratory by investigating the process capability indices (Cp，Cpk) of the 11 test items of clinical biochemical．MethodsDaily quality control data of the Second Xiangya Hospital of Central South University from August in 2014 to February in 2015 were analyzed．Cp and Cpk values were calculated for low and high levels by using the process capability index formulas and Minitab software．ResultsThere were 77 Cp in the low level including 16 Cp ≤1.33 and 61 Cp>1.33．In the other side．There were 77 Cp in the high level including 9 Cp≤1.33 and 68 Cp>1.33．ConclusionProcess capability analysis is a management method based on data and facts for decision making．It is a more objective，comprehensive and scientific management method．

参考文献/References:

［1］Juran JM，Gryna FM．Juran’s quality control handbook［M］．4th Ed．New York：McGraw-Hill Professional，1988：1-59．
[2]Dejaegher B，Jimidar M，De Smet M，et al．Improving method capability of a drug substance HPLC assay［J］．J Pharm Biomed Anal，2006，42(2)：155-170．
[3]Kamberia M，Garciab H，Feder DP，et al．Setting acceptance criteria for validation of analytical methods of drug eluting stents： Minimum requirements for analytical variability［J］．Eur J Pharm Sci，2011，42(3)：230-237．
[4]Raska CS，Bennett TS，Goodberlet SA．Risk-based analytical method transfer：application to large multi-product transfers［J］．Anal Chem，2010，82(14)：5932-5936．
[5]Gitlowa HS，Oppenheim AJ，Oppenheim R，等．质量管理［M］．张杰，译．北京：机械工业出版社，2008：95-111． Gitlowa HS，Oppenheim AJ，Oppenheim R，et al．Quality management［M］．Zhang J，Translate．Beijing：Mechanical Industry Publishing House，2008：95-111．
[6]王治国．临床检验质量控制技术［M］．3版．北京：人民卫生出版社，2014：547-553． Wang ZG．Quality control techniques of clinical laboratory［M］．3th Ed．Beijing：People’s Medical Publishing House，2014：547-553．
[7]Chesher D，Burnett L．Equivalence of critical error calculations and process capability index Cpk［J］．Clin Chem，1997，43(6pt 1)：1100-1101．
[8]黄亨建，周君，宋昊岚．质量控制过程能力指数在临床生化中的应用［J］．华西医学，2006，21(1)：96-97． Huang HJ，Zhou J，Song HL．Application of process capability index in biochemimtry［J］．West China Medical Journal，2006，21(1)：96-97．
[9]Westgard JO， Burnett RW．Precision requirements for cost-effective operation of analytical processes［J］．Clin Chem，1990，36(9)：1629-1632．
[10]Beckman N，Nightingale MJ，Pamphilon D．Practical guidelines for applying statistical process control to blood component production［J］．Transfus Med，2009，19(6)：329-339．
[11]Chen MS，Wu MS，Lin CM．Application of indices Cp and Cpk to improve quality control capability in clinical biochemistry laboratories［J］．Chin J Physiol，2014，57(2)：63-68．
[12]Dahlgaard JJ，Pettersen J，Dahlgaard-Park SM，et al．Quality and lean health care：a system for assessing and improving the health of healthcare organisations［J］．Total Qual Manag Bus Excell，2011，22(6)：673-689．

相似文献/References:

[1]阴斌霞,罗 超,刘少棠,等.基因扩增技术分析前质量控制的相关环节[J].现代检验医学杂志,2015,30(03):74.[doi:10.3969/j.issn.1671-7414.2015.03.021]
　YIN Bin-xia,LUO Chao,LIU Shao-tang,et al.Related Links of Quality Control before Polymerase Chain ReactionAnalysis[J].Journal of Modern Laboratory Medicine,2015,30(05):74.[doi:10.3969/j.issn.1671-7414.2015.03.021]
[2]张诗诗,王薇,王治国.临床检验质量控制程序的性能验证[J].现代检验医学杂志,2016,31(06):150.[doi:10.3969/j.issn.1671-7414.2016.06.045]
　ZHANG Shi-shi,WANG Wei,WANG Zhi-guo.Performance Verification of Quality Control Procedures in Clinical Laboratory Medicine[J].Journal of Modern Laboratory Medicine,2016,31(05):150.[doi:10.3969/j.issn.1671-7414.2016.06.045]
[3]张诗诗,王 薇,赵海建,等.我国血清总胆红素和直接胆红素检验项目参考区间现状与即将发布行业标准的分析比较[J].现代检验医学杂志,2017,32(03):152.[doi:10.3969/j.issn.1671-7414.2017.03.043]
　ZHANG Shi-shi,WANG Wei,ZHAO Hai-jian,et al.Analysis and Comparison of Reference Intervals of Serum Total Bilirubin and Serum Direct Bilirubinwith Upcoming I ndustry Standards in China[J].Journal of Modern Laboratory Medicine,2017,32(05):152.[doi:10.3969/j.issn.1671-7414.2017.03.043]
[4]佘　鹏,魏　欣.临床实验室骨髓细胞形态学检验的质量要求及实践思考[J].现代检验医学杂志,2019,34(06):157.[doi:10.3969 ／ j.issn.1671-7414.2019.06.040]
　SHE Peng,WEI Xin.Quality Requirements and Practical Thinking of Bone Marrow Cell Morphology Examination in Clinical Laboratory[J].Journal of Modern Laboratory Medicine,2019,34(05):157.[doi:10.3969 ／ j.issn.1671-7414.2019.06.040]
[5]蒋玲丽,朱　俊,娄　娇,等.上海市临床实验室13个常规化学检测结果互认项目检测质量分析[J].现代检验医学杂志,2021,36(04):162.[doi:10.3969/j.issn.1671-7414.2021.04.035]
　JIANG Ling-li,ZHU Jun,LOU Jiao,et al.Analysis of Mutual Recognition Items of 13 Routine Biochemistry in ShanghaiMedical Laboratories[J].Journal of Modern Laboratory Medicine,2021,36(05):162.[doi:10.3969/j.issn.1671-7414.2021.04.035]
[6]童小东,佘仕金,刘慧英,等.基于西格玛规则图法的血细胞分析室内质控控制限设定新方法[J].现代检验医学杂志,2023,38(05):190.[doi:10.3969/j.issn.1671-7414.2023.05.036]
　TONG Xiaodong,SHE Shijin,LIU huiying,et al.A New Method for Setting Quality Control Limits of Blood Cell Analysis Based on Sigma Rule Diagram Method[J].Journal of Modern Laboratory Medicine,2023,38(05):190.[doi:10.3969/j.issn.1671-7414.2023.05.036]
[7]周朝琼,王华丽,孔丽蕊,等.基于患者数据的移动中位数法在实验室血清钙和磷检测质量控制中的应用[J].现代检验医学杂志,2023,38(06):185.[doi:10.3969/j.issn.1671-7414.2023.06.034]
　ZHOU Chaoqiong,WANG Huali,KONG Lirui,et al.Application of the Moving Median Method Based on Patient Data for the Quality Control of the Serum Calcium and Phosphorus Test in the Laboratory[J].Journal of Modern Laboratory Medicine,2023,38(05):185.[doi:10.3969/j.issn.1671-7414.2023.06.034]

备注/Memo

备注/Memo:
作者简介：丁思意(1988-)，女，在读硕士，研究方向：质量控制与实验室管理，E-mail：1069571981@qq.com。
更新日期/Last Update: 1900-01-01